How many versions of Pemigatinib are there?

Release date: 2024-08-09 15:49:10     Article From: Lucius Laos     Recommended: 104

Pemigatinib is a targeted drug that is mainly used to treat cholangiocarcinoma.

How many versions of Pemigatinib are there?

From the perspective of drug specifications, Pemigatinib is available in several different dose versions to meet the treatment needs of different patients. Common sizes include 4.5mg/tablet, 9mg/tablet, and 13.5mg/tablet, and each size usually contains 14 tablets or 21 tablets (depending on the region). These different specifications of drugs have different dosages, but they all belong to the same drug ingredient Pemigatinib, but there are differences in packaging and dosage.

Availability of Pemigatinib

On April 18, 2020, the United States Food and Drug Administration (FDA) granted accelerated approval of Pemazyre (Pemigatinib) oral tablets developed by Incyte for the treatment of adult patients with treatment-experienced advanced cholangiocarcinoma. This is the world's first targeted therapy for cholangiocarcinoma.

On August 26, 2022, the FDA re-approved Pemazyre for the treatment of adults with relapsed or refractory myeloid or lymphoid tumors (MLNs) with FGFR1 rearrangements.

Clinical manifestations of cholangiocarcinoma

Cholangiocarcinoma is a malignant tumor that occurs in the bile duct system, and its symptoms vary from individual to individual, and the common symptoms include jaundice, abdominal pain, fever, etc.

1. Jaundice

Jaundice is the most common symptom of cholangiocarcinoma, and about 90%~98% of cholangiocarcinoma patients have varying degrees of skin and scleral jaundancosis. Jaundice may get worse gradually and last longer. Patients with cholangiocarcinoma usually develop jaundice at an early stage, accompanied by symptoms such as itching of the skin all over the body.

2. Abdominal pain

About half of the patients have symptoms such as right upper abdominal distension and pain, which can radiate to the back. Abdominal pain may initially resemble symptoms of cholelithiasis or cholecystitis, followed by persistent abdominal pain.

【Warm tips】When patients buy generic drugs, they should choose formal channels to ensure the quality and safety of the drugs. Avoid purchasing counterfeit products from informal sources.

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.

Contact US

Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos

E-mail:laoslucius@gmail.com

Whatsapp:

ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved